Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: The 29-item Multiple Sclerosis Impact Scale (MSIS-29) was developed to examine the impact of multiple sclerosis (MS) on physical and psychological functioning from a patient’s perspective. Objective: To determine the responder definition (RD) of the MSIS-29 physical impact subscale (PHYS) in a group of patients with relapsing–remitting MS (RRMS) participating in a clinical trial. Methods: Data from the SELECT trial comparing daclizumab high-yield process with placebo in patients with RRMS were used. Physical function was evaluated in SELECT using three patient-reported outcomes measures and the Expanded Disability Status Scale (EDSS). Anchor- and distribution-based methods were used to identify an RD for the MSIS-29. Results: Results across the anchor-based approach suggested MSIS-29 PHYS RD values of 6.91 (mean), 7.14 (median) and 7.50 (mode). Distribution-based RD estimates ranged from 6.24 to 10.40. An RD of 7.50 was selected as the most appropriate threshold for physical worsening based on corresponding changes in the EDSS (primary anchor of interest). Conclusion: These findings indicate that a ≥7.50 point worsening on the MSIS-29 PHYS is a reasonable and practical threshold for identifying patients with RRMS who have experienced a clinically significant change in the physical impact of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700
Self-citationWalters, S. J., & Brazier, J. E. (2005) · Quality of Life Research · doi:10.1007/s11136-004-7713-0 · Cited by 1,341
Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
Giordano, A., Pucci, E., Naldi, P., Mendozzi, L., Milanese, C., Tronci, F., Leone, M., Mascoli, N., La Mantia, L., Giuliani, G., et al. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.171181 · Cited by 54
Cited by
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Kappos, L., Wiendl, H., Selmaj, K., Arnold, D. L., Havrdova, E., Boyko, A., Kaufman, M., Rose, J., Greenberg, S., Sweetser, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501481 · Cited by 265
Self-citationBorland, E., Edgar, C., Stomrud, E., Cullen, N., Hansson, O., & Palmqvist, S. (2022) · Neurology · doi:10.1212/wnl.0000000000200817 · Cited by 83
Brola, W., Sobolewski, P., Fudala, M., Flaga, S., Jantarski, K., Ryglewicz, D., & Potemkowski, A. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s109520 · Cited by 35
Foshati, S., Poursadeghfard, M., Heidari, Z., & Amani, R. (2023) · Food & Function · doi:10.1039/d3fo00167a · Cited by 12
Metadata
- Authors
- Phillips, G. A., Wyrwich, K. W., Guo, S., Medori, R., Altincatal, A., Wagner, L., & Elkins, J.
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2014-04-16
- Volume
- 20
- Issue
- 13
- Pages
- 1753-1760
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2149390789
- Cited by
- 60
- References
- 3
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening. https://app.cochat.ai/papers/10.1177/1352458514530489
- The paper
- Phillips, G. A., Wyrwich, K. W., Guo, S., Medori, R., Altincatal, A., Wagner, L., & Elkins, J. (2014). Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458514530489
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.